Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6251911 | 6999915 | F | 6251911-6 | 20080901 | 20090618 | 20090630 | EXP | GR-ELI_LILLY_AND_COMPANY-GR200905002122 | ELI LILLY AND COMPANY | 46 | YR | F | Y | 20090626 | MD | GREECE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6251911 | 1011817769 | PS | STRATTERA | 1 | ORAL | UNKNOWN LOW DOSE, DAILY (1/D) | 021411 | ||||
| 6251911 | 1011817770 | SS | STRATTERA | 1 | ORAL | UP TO 40 MG, DAILY (1/D) | 021411 | ||||
| 6251911 | 1011817771 | C | BUPRENORPHINE HCL | 1 | ORAL | UNK, UNKNOWN | |||||
| 6251911 | 1011817772 | C | LADOSE | 2 | ORAL | 20 MG, UNKNOWN |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6251911 | 1011817769 | ATTENTION DEFICIT/HYPERACTIVITY DISORDER |
| 6251911 | 1011817771 | REHABILITATION THERAPY |
| 6251911 | 1011817772 | DEPRESSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6251911 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6251911 | AGGRESSION |
| 6251911 | AMENORRHOEA |
| 6251911 | HEADACHE |
| 6251911 | VOMITING |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6251911 | 1011817769 | 20080901 |